Mereo BioPharma Group plc (Mereo) (MREO) Social Stream

Mereo BioPharma Group plc (Mereo) (MREO): $1.29

-0.09 (-6.52%)

POWR Rating

Component Grades













Add MREO to Watchlist
Sign Up

Industry: Biotech


of 400

in industry

Mereo Biopharma Group plc (MREO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Mereo Biopharma Group plc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-06-25 1 $10 $8 $9 $1.29 597.67%
2022-02-17 2 $10 $8 $9 $1.29 597.67%

MREO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 0 0 0 2

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Mereo Biopharma Group plc's number of analysts covering the stock is higher than 4.67% of all US stocks.
  • In the context of all US stocks, Mereo Biopharma Group plc's upside potential (average analyst target price relative to current price) is greater than 194.56% of them.
  • MREO has a greater average analyst price target than 26.9% of Healthcare stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Mereo Biopharma Group plc's variance in analysts' estimates is lower than 66.8% of them.

Stocks similar to Mereo Biopharma Group plc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MNOV, MIST, and MIRM.

Is MREO a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5701 seconds.